Prime Medicine, Inc. (PRME) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$5.54M2021: -$34.08M2022: -$131.83M2023: -$165.41M2024: -$122.86M2025: -$162.56M-$162.56M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$162.56M-32.3%
2024-$122.86M+25.7%
2023-$165.41M-25.5%
2022-$131.83M-286.8%
2021-$34.08M-514.8%
2020-$5.54M